Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Eight APIs Recommended for Approval
September 4, 2006
- 1/3 of Drug-Related Accidents Are Due to Wrong Dosage: JCQHC
September 4, 2006
- RAPS to Initiate Training Program for Regulatory Affairs Professionals
September 4, 2006
- Results of Two Studies Announced by JPA
September 4, 2006
- REGULATORY NEWS IN BRIEF
August 28, 2006
- SELF-MEDICATION NEWS IN BRIEF
August 28, 2006
- Olympus Acquires Bacus to Provide Advanced Virtual Slide System
August 28, 2006
- NEW PRODUCTS Complete AminoMoist Lens Care Product: AMO
August 28, 2006
- Cook's Zenith Endograft Approved
August 28, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 28, 2006
- MEDICAL DEVICE NEWS IN BRIEF
August 28, 2006
- MPC Working Hard to Become a "Muscular" Company: President Komine
August 28, 2006
- Stem Cells Resembling ES Cells Induced from Mouse Skin Cells
August 28, 2006
- PI Forum Helps Member Companies Embark on New Businesses: Mr Ohyagi
August 28, 2006
- R&D NEWS IN BRIEF
August 28, 2006
- BUSINESS NEWS IN BRIEF
August 28, 2006
- NEW PRODUCTS
August 28, 2006
- COMMENTARY／Korosho Gets Involved to Eliminate Provisional Delivery
August 28, 2006
- Drug Development Beyond Borders -Today's Global Cooperative Clinical Trials-
August 28, 2006
- Drug Firms Should Support Job Sharing between Regional Med. Institutions: Mr Matsubara
August 28, 2006
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…